Q3 2025 · 13F-HR
Exome Asset Management LLCholdings as filed
Filed 2025-11-14 · accession 0001420506-25-003369
$165.1M
Reported value
68
Positions
2025-09-30
Period end
The Brief · Exome Asset Management LLC · Q3 2025
AI · grounded in 13F
Exome Asset Management LLC established a new position in IONS valued at $8.57M. The fund also initiated new stakes in CYTK for $7.83M and BBIO for $6.91M. Additional new positions include COGT, GH, and LLY.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $8.6M | 5.19% | 131,016 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $7.8M | 4.74% | 142,417 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $6.9M | 4.19% | 133,087 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $6.4M | 3.86% | 443,547 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $6.1M | 3.71% | 98,182 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $6.0M | 3.63% | 7,852 | Common | SOLE |
| 44975P103 | NBP | I MAB | $5.4M | 3.30% | 1,439,604 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $5.4M | 3.27% | 101,996 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $4.5M | 2.75% | 156,072 | Common | SOLE |
| 046353108 | AZNN | ASTRAZENECA PLC | $4.3M | 2.59% | 28,362 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $4.1M | 2.46% | 61,356 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $4.0M | 2.44% | 273,661 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $3.8M | 2.27% | 94,400 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $3.8M | 2.27% | 156,917 | Common | SOLE |
| 88033G407 | THC | TENET HEALTHCARE CORP | $3.7M | 2.23% | 18,100 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $3.6M | 2.18% | 104,507 | Common | SOLE |
| 126650100 | CVS | CVS HEALTH CORP | $3.3M | 1.99% | 43,600 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $3.3M | 1.98% | 48,445 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $3.0M | 1.82% | 18,650 | Common | SOLE |
| 21833P301 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $2.9M | 1.76% | 229,962 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $2.8M | 1.72% | 6,358 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $2.8M | 1.70% | 173,439 | Common | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP DEL | $2.8M | 1.69% | 6,645 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $2.8M | 1.68% | 58,579 | Common | SOLE |
| 92189F692 | PPH | VANECK ETF TRUST | $2.7M | 1.64% | 30,000 | CALL | SOLE |
| 89422G907 | TVTX | TRAVERE THERAPEUTICS INC | $2.6M | 1.59% | 110,000 | CALL | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $2.6M | 1.55% | 158,622 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $2.5M | 1.54% | 1,858,354 | Common | SOLE |
| 23284F105 | CTMX | CYTOMX THERAPEUTICS INC | $2.4M | 1.44% | 745,305 | Common | SOLE |
| 70975L107 | PEN | PENUMBRA INC | $2.3M | 1.38% | 9,000 | Common | SOLE |
| 377322102 | GKOS | GLAUKOS CORP | $2.2M | 1.34% | 27,143 | Common | SOLE |
| 53635D202 | LQDA | LIQUIDIA CORPORATION | $2.1M | 1.30% | 94,235 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $2.1M | 1.29% | 88,024 | Common | SOLE |
| 670100905 | NVO | NOVO-NORDISK A S | $1.9M | 1.18% | 35,000 | CALL | SOLE |
| 88025U109 | TXG | 10X GENOMICS INC | $1.9M | 1.16% | 163,658 | Common | SOLE |
| 03073E105 | COR | CENCORA INC | $1.9M | 1.14% | 6,000 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $1.8M | 1.10% | 117,783 | Common | SOLE |
| 946784105 | WAY | WAYSTAR HLDG CORP | $1.8M | 1.08% | 46,900 | Common | SOLE |
| 803607AD2 | SRPT 1.25 09/15/27 | SAREPTA THERAPEUTICS INC | $1.8M | 1.07% | 2,000,000 | Common | SOLE |
| 48576UAA4 | KPTI 3 10/15/25 | KARYOPHARM THERAPEUTICS INC | $1.6M | 0.99% | 2,000,000 | Common | SOLE |
| 913903100 | UHS | UNIVERSAL HLTH SVCS INC | $1.6M | 0.98% | 7,955 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $1.4M | 0.88% | 120,644 | Common | SOLE |
| 74276L105 | PRCT | PROCEPT BIOROBOTICS CORP | $1.4M | 0.86% | 39,900 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $1.4M | 0.84% | 18,600 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $1.3M | 0.78% | 22,090 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $1.3M | 0.77% | 178,084 | Common | SOLE |
| 05338F306 | AVTX | AVALO THERAPEUTICS INC | $1.3M | 0.77% | 100,036 | Common | SOLE |
| 53635D952 | LQDA | LIQUIDIA CORPORATION | $1.2M | 0.73% | 53,000 | PUT | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $1.2M | 0.72% | 451,699 | Common | SOLE |
| 022307102 | ALMS | ALUMIS INC | $1.2M | 0.71% | 292,770 | Common | SOLE |
| 91678A107 | UPB | UPSTREAM BIO INC | $977,368 | 0.59% | 51,960 | Common | SOLE |
| 03969T959 | ARCT | ARCTURUS THERAPEUTICS HLDGS | $921,500 | 0.56% | 50,000 | PUT | SOLE |
| 55287L101 | MBX | MBX BIOSCIENCES INC | $917,035 | 0.56% | 52,402 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $908,951 | 0.55% | 98,799 | Common | SOLE |
| 55287L951 | MBX | MBX BIOSCIENCES INC | $883,750 | 0.54% | 50,500 | PUT | SOLE |
| 19240Q901 | COGT | COGENT BIOSCIENCES INC | $646,200 | 0.39% | 45,000 | CALL | SOLE |
| 152309950 | CNTA | CENTESSA PHARMACEUTICALS PLC | $606,250 | 0.37% | 25,000 | PUT | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $536,969 | 0.33% | 13,100 | Common | SOLE |
| 74006W907 | PRAX | PRAXIS PRECISION MEDICINES I | $530,000 | 0.32% | 10,000 | CALL | SOLE |
| 55287L901 | MBX | MBX BIOSCIENCES INC | $525,000 | 0.32% | 30,000 | CALL | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $426,800 | 0.26% | 20,000 | PUT | SOLE |
| 03879J100 | ABUS | ARBUTUS BIOPHARMA CORP | $342,697 | 0.21% | 75,484 | Common | SOLE |
| 74017N955 | PGEN | PRECIGEN INC | $329,000 | 0.20% | 100,000 | PUT | SOLE |
| 48576U955 | KPTI | KARYOPHARM THERAPEUTICS INC | $314,574 | 0.19% | 48,100 | PUT | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $308,443 | 0.19% | 73,614 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $188,466 | 0.11% | 60,600 | Common | SOLE |
| 4525EP101 | VTLUSD | IMMUNIC INC | $153,310 | 0.09% | 173,900 | Common | SOLE |
| 002120202 | ATYR | ATYR PHARMA INC | $28,840 | 0.02% | 40,000 | CALL | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.